In Vitro Assessment of the Neuro-Compatibility of Fe-20Mn as a Potential Bioresorbable Material for Craniofacial Surgery.
Sara AjamiCharlotte KraaneveldMaarten KoudstaalDavid DunawayNoor Ul Owase JeelaniSilvia SchievanoChiara BregoliJacopo FiocchiCarlo Alberto BiffiAusonio TuissiAlessandro BorghiPublished in: Medicina (Kaunas, Lithuania) (2024)
Background and Objectives: Spring-assisted surgery is a popular option for the treatment of non-syndromic craniosynostosis. The main drawback of this procedure is the need for a second surgery for spring removal, which could be avoided if a distractor material could be metabolised over time. Iron-Manganese alloys (FeMn) have a good trade-off between degradation rate and strength; however, their biocompatibility is still debated. Materials and Methods: In this study, the neuro-compatibility of Fe-20Mn (wt.%) was assessed using standard assays. PC-12 cells were exposed to Fe-20Mn (wt.%) and stainless steel via indirect contact. To examine the cytotoxicity, a Cell Tox Green assay was carried out after 1, 2, and 3 days of incubation. Following differentiation, a neurite morphological examination after 1 and 7 days of incubation time was carried out. The degradation response in modified Hank's solution at 1, 3, and 7 days was investigated, too. Results: The cytotoxicity assay showed a higher toxicity of Fe-20Mn than stainless steel at earlier time points; however, at the latest time point, no differences were found. Neurite morphology was similar for cells exposed to Fe-20Mn and stainless steel. Conclusions: In conclusion, the Fe-20Mn alloy shows promising neuro-compatibility. Future studies will focus on in vivo studies to confirm the cellular response to Fe-20Mn.
Keyphrases
- metal organic framework
- minimally invasive
- room temperature
- transition metal
- coronary artery bypass
- high throughput
- aqueous solution
- single cell
- induced apoptosis
- mass spectrometry
- risk assessment
- mesenchymal stem cells
- percutaneous coronary intervention
- cell proliferation
- bone marrow
- autism spectrum disorder
- signaling pathway
- single molecule